Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy

Transplant International

Volumn 23, Issue 2, 2010, Pages 169-175

  Han, Seung Seok ^a   Huh, Wooseong ^b   Park, Su Kil ^c   Ahn, Curie ^a   Han, Jin Suk ^a   Kim, Suhnggwon ^a   Kim, Yon Su ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Chronic allograft nephropathy; Graft survival; IgA nephropathy; Recurrence

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC ALLOGRAFT NEPHROPATHY; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CADAVER; CHILD; CHRONIC DISEASE; FEMALE; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73449124456     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00966.x     Document Type: Article

References (22)

1. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008 51 : S1.
2. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987 64 : 709.
3. Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: a morphological and clinical study. Clin Nephrol 1987 27 : 131.
4. Radford MG, Jr., Donadio JV, Jr., Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997 8 : 199.
5. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 1988 84 : 129.
6. Schena FP. Immunoglobulin A nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists. Am J Med 2001 110 : 499.
7. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002 347 : 103.
8. Berger J, Yaneva H, Nabarra B, Barbanel C. Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int 1975 7 : 232.
9. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006 6 : 2535.
10. Wang AY, Lai FM, Yu AW, et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001 38 : 588.
11. Choy BY, Chan TM, Lo SK, Lo WK, Lai KN. Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant 2003 18 : 2399.
12. Freese P, Svalander C, Norden G, Nyberg G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999 13 : 313.
13. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001 56 : 279.
14. McDonald SP, Russ GR. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches. Transplantation 2006 82 : 759.
15. Jennette JC. The immunohistology of IgA nephropathy. Am J Kidney Dis 1988 12 : 348.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461.
17. Kim YS, Moon JI, Jeong HJ, et al. Live donor renal allograft in end-stage renal failure patients from immunoglobulin A nephropathy. Transplantation 2001 71 : 233.
18. Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Nephrol Dial Transplant 2005 20 : 1214.
19. Maes BD, Oyen R, Claes K, et al. Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study. Kidney Int 2004 65 : 1842.
20. Berthoux F, Deeb SE, Mariat C, Diconne E, Laurent B, Thibaudin L. Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary IgA nephropathy. Transplantation 2008 85 : 1505.
21. Jeong HJ, Huh KH, Kim YS, Kim SI. IgA nephropathy in renal allografts-recurrence and graft dysfunction. Yonsei Med J 2004 45 : 1043.
22. Sumethkul V, Jirasiritham S, Chalermsanyakorn P, Buranachokpaisan W. Chronic rejection: a significant predictor of poor outcome for recurrence IgA nephropathy. Transplant Proc 2001 33 : 3375.